Presentation is loading. Please wait.

Presentation is loading. Please wait.

Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes  Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,

Published byAudra Skinner Modified over 5 years ago

Similar presentations

Presentation on theme: "Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes  Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,"— Presentation transcript:

1 Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes 
Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier, MD, Michael Shullo, PharmD, Kathleen Lockard, RN, Rachelle Zomak, BSN, Dennis McNamara, MD, Yoshiya Toyoda, MD, Robert L. Kormos, MD, Jeffrey J. Teuteberg, MD  The Annals of Thoracic Surgery  Volume 92, Issue 4, Pages (October 2011) DOI: /j.athoracsur Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Survival after mechanical circulatory support.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Change in body mass index after mechanical circulatory support (MCS) by preimplant category of body mass index. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Survival after transplant: nonobese versus obese.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Change in weight after mechanical circulatory support (MCS) and cardiac transplantation (xplant): nonobese versus obese. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes  Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,"

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,
Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.
Management of Anticoagulation in Patients with Mechanical Circulatory Support Using a Physician-Based Versus a Pharmacist Directed Anticoagulation Clinic-Based.

Management of Anticoagulation in Patients with Mechanical Circulatory Support Using a Physician-Based Versus a Pharmacist Directed Anticoagulation Clinic-Based.
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
What Predicts Long-Term Survival After Heart Transplantation

What Predicts Long-Term Survival After Heart Transplantation
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Clinical Outcomes in Patients With Prolonged Intensive Care Unit Length of Stay After Cardiac Surgical Procedures  Ansar Hassan, MD, PhD, Curtis Anderson,

Clinical Outcomes in Patients With Prolonged Intensive Care Unit Length of Stay After Cardiac Surgical Procedures  Ansar Hassan, MD, PhD, Curtis Anderson,
Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,
Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations  W. Brent Keeling, MD, Jose Binongo, PhD, Eric.

Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations  W. Brent Keeling, MD, Jose Binongo, PhD, Eric.
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Trevor Williams, MD, MPH, Brian C

Trevor Williams, MD, MPH, Brian C
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda.

Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda.
Does Diabetes Affect the Postoperative Outcomes After Total Arterial Off-Pump Coronary Bypass Surgery in Multivessel Disease?  Jae-Sung Choi, MD, PhD,

Does Diabetes Affect the Postoperative Outcomes After Total Arterial Off-Pump Coronary Bypass Surgery in Multivessel Disease?  Jae-Sung Choi, MD, PhD,
Richard K. Freeman, MD, Anthony J. Ascioti, MD, Jaclyn M

Richard K. Freeman, MD, Anthony J. Ascioti, MD, Jaclyn M
Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery  Jason Brase, MS, Brooke Finger, MS,

Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery  Jason Brase, MS, Brooke Finger, MS,
Super-Charged Pedicled Jejunal Interposition Performance Compares Favorably With a Gastric Conduit After Esophagectomy  Elizabeth H. Stephens, MD, PhD,

Super-Charged Pedicled Jejunal Interposition Performance Compares Favorably With a Gastric Conduit After Esophagectomy  Elizabeth H. Stephens, MD, PhD,
Blood Pressure Control in Continuous Flow Left Ventricular Assist Devices: Efficacy and Impact on Adverse Events  Brent C. Lampert, DO, Chad Eckert, PhD,

Blood Pressure Control in Continuous Flow Left Ventricular Assist Devices: Efficacy and Impact on Adverse Events  Brent C. Lampert, DO, Chad Eckert, PhD,
David Badrudin, MD, Feras Khaliel, MD, Raymond Cartier, MD 

David Badrudin, MD, Feras Khaliel, MD, Raymond Cartier, MD 
Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J

Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J

Similar presentations

Ads by Google